Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68,652,138
-
Total 13F shares
-
2,169,473
-
Share change
-
+412,370
-
Total reported value
-
$8,073,000
-
Put/Call ratio
-
38%
-
Price per share
-
$3.73
-
Number of holders
-
32
-
Value change
-
+$1,421,026
-
Number of buys
-
17
-
Number of sells
-
9
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q4 2021
As of 31 Dec 2021,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,169,473 shares.
The largest 10 holders included
VANGUARD GROUP INC, TWO SIGMA ADVISERS, LP, RICE HALL JAMES & ASSOCIATES, LLC, TWO SIGMA INVESTMENTS, LP, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Diametric Capital, LP, STATE STREET CORP, Richmond Brothers, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.